PD34-02 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY

MLA

J.R. Karnes, et al. “Pd34-02 the Key Role of Psa Doubling Time in Patients Treated with Salvage Radiation Therapy After Radical Prostatectomy: Implications for the Extent of Radiation and the Concomitant Use of Hormonal Therapy.” Journal of Urology, vol. 206, Sept. 2021. EBSCOhost, https://doi.org/10.1097/ju.0000000000002038.02.

APA

J.R. Karnes, N. Di Muzio, Detlef Bartkowiak, F. Montorsi, S.F. Shariat, Gregor Goldner, G. Gandaglia, Alberto Bossi, S. Joniau, A. Briganti, G. De Meerleer, Thomas Wiegel, B. Noris Chiorda, H. Van Poppel, Elio Mazzone, Cesare Cozzarini, Charlien Berghen, Stephen A. Boorjian, T. Kumar, … Daniele Robesti. (2021). Pd34-02 the Key Role of Psa Doubling Time in Patients Treated with Salvage Radiation Therapy After Radical Prostatectomy: Implications for the Extent of Radiation and the Concomitant Use of Hormonal Therapy. Journal of Urology, 206. https://doi.org/10.1097/ju.0000000000002038.02

Chicago

J.R. Karnes, N. Di Muzio, Detlef Bartkowiak, F. Montorsi, S.F. Shariat, Gregor Goldner, G. Gandaglia, et al. 2021. “Pd34-02 the Key Role of Psa Doubling Time in Patients Treated with Salvage Radiation Therapy After Radical Prostatectomy: Implications for the Extent of Radiation and the Concomitant Use of Hormonal Therapy.” Journal of Urology 206 (September). doi:10.1097/ju.0000000000002038.02.